Navigation Links
NexBio to Present at 2007 BIOCOM Investor Conference
Date:10/31/2007

SAN DIEGO, Oct. 31 /PRNewswire/ -- NexBio, Inc. a privately held development-stage biopharmaceutical company located in San Diego, announced today that Dr. David Wurtman, its Vice President of Corporate Development, will present a corporate overview and update at the BIOCOM Investor Conference on November 1, 2007.

NexBio's mission is to save lives, and to improve the quality of life, by creating and commercializing novel, broad-spectrum biopharmaceuticals to prevent and treat current and emerging life-threatening human viral respiratory diseases. NexBio has received significant financial support through grants and contracts from the National Institutes of Health for development of Fludase(TM), its lead program, a first-in-class broad-spectrum prophylactic and therapeutic agent to potentially address all annual and pandemic variations of influenza, including the Avian IFV H5N1 ("Bird Flu"), as well as parainfluenza. Product candidates in NexBio's pipeline may address additional viral infections, such as RSV.

The company also possesses TOSAP(TM), a novel, elegant, flexible & scalable formulation technology, invented by NexBio scientists, which it uses to make dry-powder microspheres to allow drugs to be delivered by inhalation. TOSAP(TM) is being applied to expand the company's pipeline, and is also being licensed to partners who wish to formulate their own compounds.

NexBio is actively seeking corporate partnerships from companies that have extensive experience in late stage drug development and commercialization, as well as entertaining inquiries from financing sources that may wish to invest in the company.

For more information about NexBio, Inc., please visit http://www.nexbio.com

Contact:

David Wurtman, M.D., M.B.A

VP, Corporate Development

10665 Sorrento Valley Road

San Diego, CA 92121

Phone: (858) 452-2631

dwurtman@nexbio.com

Note: FDA has yet to approve the name Fludase.


'/>"/>
SOURCE NexBio, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
Breaking Medicine Technology: